World’s first study of Pfizer vaccine in Israel shows 92 percent effectiveness
Health provider said:'This is very, very good news. It is the first study in the world that looks at such a large number of fully vaccinated patients'
The world’s first big and controlled study of the effectiveness of Pfizer’s Covid-19 vaccine has taken place in Israel and shown a 92 percent effectiveness level.
It has led to sighs of relief around the world, after the statistics came in close to the pharmaceutical giant’s own claim that its vaccine offered 95 percent protection.
“This is a very high figure, well within the standard deviation we would expect,” said Professor Eyal Leshem, infectious diseases specialist at Sheba Medical Center, speaking to Times of Israel.
Maccabi Healthcare Services, which led the study, said: “This is very, very good news. It is the first study in the world that looks at such a large number of fully vaccinated patients.”
More than a third of Israelis have now been given or offered the vaccine and the country’s health ministry said it was now offering to inoculate the next age tier, which is those over 35 years of age.
Students in exam years are also now being offered the jab to avoid disrupting their entrance process to university or the military.
comments